Metrics

Agreed Proposals

The table below provides details of approved Research Proposals that have signed Data Sharing Agreements.

Click here to download the Agreed Proposals Report.

Proposal number Sponsor/Funder Title Lead researcher  
611 GSK Long-acting beta2-agonists for chronic obstructive pulmonary disease Kayleigh Kew Further Details
628 GSK Predictive and Prognostic Value of Blood Cell Ratios in Patients with Metastatic Renal Cell Carcinoma Treated with Pazopanib Arnoud J. Templeton, MD Further Details
631 GSK Predictors of BPH Progression Dr. Stephen Freedland, MD Further Details
637 GSK Relationship of Activated Clotting Time and Bleeding Related Outcomes in the FUTURA OASIS-8 Trial Sripal Bangalore Further Details
639 GSK Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux in Patients with Peripheral Arterial Disease Saurav Chatterjee MD Further Details
645 GSK The Influence of Age, Gender, and Race on the Effects of Combination Therapy with Carvedilol plus Lisinopril Versus Lisinopril Monotherapy for Systemic Hypertension Partha Sardar Further Details
646 GSK Factors influencing immune response and patient outcomes following influenza vaccination. Dr Subhadra Rajanaidu Further Details
647 GSK Assessing and Reporting Heterogeneity of Treatment Effect in Randomized Clinical Trials David M. Kent, MD, MSc Further Details
651 GSK Descriptive evaluation of SAE reporting rates in vaccine clinical trials among Latin American children. Thomas Verstraeten Further Details
653 GSK Functional Estimation of Interventional Effects Joon Park Further Details
First 1 2 3 4 5  ... Last